Narrative review / 2024
Common cholesterol-lowering dietary supplements have a limited clinical role due to inconsistent trial results and quality concerns.
This review evaluates common dietary supplements marketed for cholesterol reduction and cardiovascular benefits. Fish oil and niacin have a limited or negligible role in lipid management based on mixed findings, safety concerns, and major guidelines. While red yeast rice reduces LDL-C, and supplements such as garlic, phytosterols, psyllium, and berberine show modest LDL-C reductions, inconsistent study results and product quality issues persist. The authors conclude that these supplements have a limited role in clinical practice until they consistently match label claims and are free of contaminants.
- Study type
- Narrative review
- Who was studied
- Individuals considering cholesterol-lowering dietary supplements
- What was measured
- Efficacy and safety of common dietary supplements for lipid management
THE PAPER
A Clinicians Guide to Recommending Common Cholesterol-Lowering Dietary Supplements.
Backes JM, Hilleman DE. Am J Cardiovasc Drugs, 2024.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.